Entyvio® accepted for moderately to severely active ulcerative colitis
Suitable for adult patients who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a TNFα antagonist.
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via